Skip to main content
Clinical Trials/IRCT2014102719145N2
IRCT2014102719145N2
Completed
Phase 2

A Clinical trial Of Analgesic Effects, Hemodynamic Changes And Postoperative Nausea And Vomiting After Intrathecal Injection Of Bupivacaine Plus Midazolam , Bupivacaine Plus Pethidine Or Bupivacaine Alone In Elective Cesarean Section

Fasa University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Spinal Block in elective cesarean.
Sponsor
Fasa University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Fasa University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: Full\-term pregnant women; candidate for non\-emergent cesarean section (elective cesarean, previous cesarean, cephalopelvic disproportion, malpresentation); American Society of Anesthesiologists physical status I or II

Exclusion Criteria

  • contraindication for intrathecal injection; allergy to midazolam or pethidine; systemic diseases (such as diabetes, hypertension and preeclampsia)

Outcomes

Primary Outcomes

Not specified

Similar Trials